Abstract:Abstract Background The small number of samples and the curse of dimensionality hamper the better application of deep learning techniques for disease classification. Additionally, the performance of clustering-based feature selection algorithms is still far from being satisfactory due to their limitation in using unsupervised learning methods. To enhance interpretability and overcome this problem, we developed a novel feature selection algorithm. In the meantime, complex genomic data brought great challenges for the identification of biomarkers and therapeutic targets. The current some feature selection methods have the problem of low sensitivity and specificity in this field. Results In this article, we designed a multi-scale clustering-based feature selection algorithm named MCBFS which simultaneously performs feature selection and model learning for genomic data analysis. The experimental results demonstrated that MCBFS is robust and effective by comparing it with seven benchmark and six state-of-the-art supervised methods on eight data sets. The visualization results and the statistical test showed that MCBFS can capture the informative genes and improve the interpretability and visualization of tumor gene expression and single-cell sequencing data. Additionally, we developed a general framework named McbfsNW using gene expression data and protein interaction data to identify robust biomarkers and therapeutic targets for diagnosis and therapy of diseases. The framework incorporates the MCBFS algorithm, network recognition ensemble algorithm and feature selection wrapper. McbfsNW has been applied to the lung adenocarcinoma (LUAD) data sets. The preliminary results demonstrated that higher prediction results can be attained by identified biomarkers on the independent LUAD data set, and we also structured a drug-target network which may be good for LUAD therapy. Conclusions The proposed novel feature selection method is robust and effective for gene selection, classification, and visualization. The framework McbfsNW is practical and helpful for the identification of biomarkers and targets on genomic data. It is believed that the same methods and principles are extensible and applicable to other different kinds of data sets.

Gene selection and cancer classification using Monte Carlo and nonnegative matrix factorization

Nim: A Node Influence Based Method for Cancer Classification

Cancer classification and pathway discovery using non-negative matrix factorization

Tumor Classification Using Non-negative Matrix Factorization

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

Parameters Selection in Gene Selection Using Gaussian Kernel Support Vector Machines by Genetic Algorithm

Gene Selection for Cancer Classification using Support Vector Machines

Gene selection for cancer classification using a hybrid of univariate and multivariate feature selection methods

An Efficient Nonnegative Matrix Factorization Model for Finding Cancer Associated Genes by Integrating Data from Genome, Transcriptome and Interactome.

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data

Gene selection and classification for cancer microarray data based on machine learning and similarity measures

On -Divergence Based Nonnegative Matrix Factorization for Clustering Cancer Gene Expression Data

Cancer Classification Using Entropy Analysis in Fractional Fourier Domain of Gene Expression Profile

Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning

Gene-MOE: A sparsely gated prognosis and classification framework exploiting pan-cancer genomic information

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Fuzzy Gene Selection and Cancer Classification Based on Deep Learning Model

On α-divergence based nonnegative matrix factorization for clustering cancer gene expression data

Gene Expression-Based Cancer Classification for Handling the Class Imbalance Problem and Curse of Dimensionality

Low-Rank Reorganization via Proportional Hazards Non-negative Matrix Factorization Unveils Survival Associated Gene Clusters